Prescient Therapeutics LimitedASX: PTX

First patient at Moffitt dosed in Phase 1b/2 breast trial

Sep 26, 2016 at 4:03 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment